• Cost-Effectiveness Analysis of Dapaglifozin Versus Other T2DM Treatments in the Spanish Context

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Las Vacunas Neumocócicas 13-Valente Y 23-Valente Para Adultos De Alto Riesgo En Colombia

    Nov 1, 2013, 00:00

  • Patient Preference for Oral Versus Injectable and Intravenous Methods of Treatment for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients- Comparison with Matched Controls

    Nov 1, 2013, 00:00

  • Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc Study

    Nov 1, 2013, 00:00

  • Variations in Treatment Patterns and Disease Severity Among Patients with Psoriasis Receiving Their First Biologic in European Union

    Nov 1, 2013, 00:00

  • Racial Disparities in Diffusion, Comparative Morbidity, and Disease Control of Intensity-Modulated Radiation Therapy Compared to Conformal Radiation Therapy for Localized Prostate Cancer

    Nov 1, 2013, 00:00

  • Quality Indicators of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Programme

    Nov 1, 2013, 00:00

  • Correlation Between Montgomery-Asberg Depression Rating Scale (MADRS) and the Beck Depression Inventory II (BDI-II) in Patients with Focal Epilepsy

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Catheter Ablation as First-Line Treatment

    Nov 1, 2013, 00:00

  • Instructions for Authors

    Nov 1, 2013, 00:00

  • Comparison of Drug Assessments in France, Germany and the United Kingdom- Is European HTA a Reality?

    Nov 1, 2013, 00:00

  • The Association Between European Medicines Agency Approval and Health Technology Assessment Recommendation

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany

    Nov 1, 2013, 00:00

  • The Efficiency of Preoperative Physiotherapy in Patients with Chronic Obstructive Pulmonary Disease Undergoing Open Heart Surgery

    Nov 1, 2013, 00:00

  • Interruption/Bridging of VKA Treatment of Patients with Atrial Fibrillation- Analysis of Incidence and Clinical Outcomes Based on a German Claims Based Data Set

    Nov 1, 2013, 00:00

  • Calidad De Prescripción De Antibióticos En El Servicio De Pediatria De Un Hospital General De Cardenas, Tabasco, México

    Nov 1, 2013, 00:00

  • Update on Pharmacoeconomics in Nutrition- Parenteral Glutamine Supplement in Intensive Care Unit Patients

    Nov 1, 2013, 00:00

  • DETERMINING THE MAGNITUDE OF A DETECTABLE AND A RELEVANT TREATMENT BENEFIT IN AESTHETIC MEDICINE USING A PHOTOGUIDE AND THE INTERNET

    Nov 1, 2013, 00:00

  • Estimating Prevalence of Prostate Cancer Clinical States Using a Dynamic Patient Progression Model

    Nov 1, 2013, 00:00

  • A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Linezolid Comparado Con Vancomicina En El Manejo De La Neumonía Asociada A La Ventilación Mecanica En Colombia

    Nov 1, 2013, 00:00

  • Systematic Review on Use of Economic Evidence by Clinical Guidelines

    Nov 1, 2013, 00:00

  • Eficácia E Segurança De Ranibizumabe E Bevacizumabe No Tratamento De Degeneração Macular Relacionada a Idade

    Nov 1, 2013, 00:00

  • EQ-5D-5L Crosswalk Value Set for Poland

    Nov 1, 2013, 00:00

  • Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • Factors Associated with Early Response to Olanzapine and Clinical and Functional Outcomes of Early Responders Treated for Schizophrenia in China

    Nov 1, 2013, 00:00

  • Costs Associated with the Impact of Progressive Multiple Sclerosis- Insights from a Three Year Clinical Trial (The Cupid Trial)

    Nov 1, 2013, 00:00

  • Pre-Financing Function of the Pharmaceutical Full-Line Wholesale Sector in the European Union

    Nov 1, 2013, 00:00

  • Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 Countries

    Nov 1, 2013, 00:00

  • Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)

    Nov 1, 2013, 00:00

  • Health Related Quality of Life of Patients with Bladder Cancer in Hungary

    Nov 1, 2013, 00:00

  • Therapy Escalation Thresholds and the Potential for Biased Cost Effectiveness Analysis When Failing to Sample Baseline HbA1c in Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Inhaled Corticosteroids (ICS) in Treatment of Moderate and Severe Asthma in Russian Federation – Comparative Pharmacoeconomic Study

    Nov 1, 2013, 00:00

  • The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United Kingdom

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis

    Nov 1, 2013, 00:00

  • Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple Myeloma

    Nov 1, 2013, 00:00

  • Correlation Between Prognostic Factors and Non Prosthetic Further Fracture Related Treatment After Femoral Neck Fracture Underwent Internal Fixation in Elderly

    Nov 1, 2013, 00:00

  • Permanent Transvenous Lead Extraction- Factors Influencing the Difficulty of the Procedure

    Nov 1, 2013, 00:00

  • How University Hospital of Crete Succeeded in Decreasing Cytostatics’ Budget in 2012?

    Nov 1, 2013, 00:00

  • Chemotherapy Treatment Patterns, Health Care Costs, and Mortality of Lung Cancer Patients in Taiwan – A Longitudinal Study Between 2000 and 2008

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Liraglutide Versus Sitagliptin in Type 2 Diabetes in the United Kingdom- A Retrospective Study in Primary Care

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Model Comparing Sub-Cutaneous Biologic Treatment for Severe Plaque Psoriasis in Mexico

    Nov 1, 2013, 00:00

  • Statins in Canada- The Case for Disinvestment

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in Greece

    Nov 1, 2013, 00:00

  • What Are the Clinical and Economic Costs and Benefits of Implementing Point of Care Tests for Chlamydia Trachomatis and Neisseria Gonorrhoea in Genito-Urinary Medicine Clinics in the United Kingdom?

    Nov 1, 2013, 00:00

  • Illustration of the Combined Effect of Patient’s Adherence and Individual Biological Characteristics on Blood Pressure

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Assessment of Ranibizumab in the Treatment of the Diabetic Retinopathy in the Russian Federation

    Nov 1, 2013, 00:00

  • Variances in Individuals’ Prescription Drug Costs in Ireland

    Nov 1, 2013, 00:00

  • Comparisons of the Clinical Effectiveness of Treatments for the Symptoms Associated with Overactive Bladder (OAB)

    Nov 1, 2013, 00:00

  • Assessment and Causal Link Between Vision-Related Quality of Life and General Health Related Quality of Life in Dry Eye Patients

    Nov 1, 2013, 00:00

  • Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United Kingdom

    Nov 1, 2013, 00:00

  • Additional Clinical Benefit for Patient Relevant Endpoints- Investment Disincentives by AMNOG in the Example of Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Cognitive-Behavioral Therapy for Major Depressive Disorder – A Systematic Review

    Nov 1, 2013, 00:00

  • Impact of Dosage and Seven Other Factors in the Adherence to Oral Medication in People with Diabetes Type 2 in Germany

    Nov 1, 2013, 00:00

  • Do EMA and FDA Have Different Opinions/Requirements in Terms of Pediatric Studies for Sitagliptin (Alone or in Combination)?

    Nov 1, 2013, 00:00

  • Patient Preferences on Treatments for Erectil Dysfunction Defined by Means of Different Attribute Groups- The Method of Administration Is the Most Valued Attribute and the Orodispersible Tablet Is the Most Preferred Level

    Nov 1, 2013, 00:00

  • Assessing the Future Burden of Renal Replacement Therapy in the United Kingdom

    Nov 1, 2013, 00:00

  • Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected Studies

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

    Nov 1, 2013, 00:00

  • Are “Dizzy” and “Lightheaded” the Same Concept or Separate Concepts? Challenges in Conceptual Equivalence of These Terms in 20 Languages

    Nov 1, 2013, 00:00

  • Impact of Switching on Health Care Costs and Outcomes in Generic Drug Policies

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Venous Thromboemoblism- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fluoroquinolone-Based Regimens for the Treatment of Community-Acquired Pneumonia in a Multi-Field Hospital in Russia

    Nov 1, 2013, 00:00

  • The Nice Medical Technology Evaluation Programme (MTEP) – Insights for Manufacturers Considering Notification

    Nov 1, 2013, 00:00

  • Attitudes of Physicians Toward Implementing Shared Medical Appointments at National Guard Family Medicine Centers in Riyadh

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States

    Nov 1, 2013, 00:00

  • ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT- RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY

    Nov 1, 2013, 00:00

  • Budget Impact of Switching Pramipexole Immediate Release to Pramipexole Extended Release in Treatment of Parkinson’s Disease; Perspective of the Social Security Institution

    Nov 1, 2013, 00:00

  • Safety in National Care - Real World Data from the German Psoriasis-Registry “Psobest”

    Nov 1, 2013, 00:00

  • Comparación Del Trabajo En Equipo En Salas De Cirugía Entre Un Hospital Privado Y Uno Público De Bogotá, D.C

    Nov 1, 2013, 00:00

  • Societal Unmet Needs in Brazil- Examining Prevalence, Treatment Rates, and Health Outcomes

    Nov 1, 2013, 00:00

  • Impact of Value Communication in Decision Making- An Approach to the Treatment of Type 2 Diabetes in Portugal

    Nov 1, 2013, 00:00

  • Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology- A Willingness-To-Participate Study

    Nov 1, 2013, 00:00

  • Medical Cards During Recession- How Many, for Whom and How Much?

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Gastroesophageal Reflux Disease in Slovakia

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients with Prostate Cancer in the United States

    Nov 1, 2013, 00:00

  • The Efficacy of the Extra Front Loading Smoking Cessation Counselling Sessions on the Abstinence Rate Compared with Usual Care Used in Quit Smoking Clinic in Penang, Malaysia

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Ivabradine Use in Belarus

    Nov 1, 2013, 00:00

  • Total Costs and Outcomes of Drug-Eluting Stent Placement with Intravascular Ultrasound (IVUS) Compared with Angiography Alone- A Cost-Effectiveness Analysis from the Perspective of the Italian Health System

    Nov 1, 2013, 00:00

  • Screen or Not to Screen for Peripheral Arterial Disease- Guidance from a Decision Model

    Nov 1, 2013, 00:00

  • Cost-Utility of Rheumatoid Arthritis Monotherapy with Tocilizumab in Spain

    Nov 1, 2013, 00:00

  • Treatment Adherence and Costs in Multiple Sclerosis- A Narrative Review of the Literature

    Nov 1, 2013, 00:00

  • Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

    Nov 1, 2013, 00:00

  • A Systematic Review of Cost-Of-Illness Studies and Cost-Effectiveness Analyses in Borderline Personality Disorder

    Nov 1, 2013, 00:00

  • A Non-Interventional Retrospective Evaluation of Resources Consumed During the Provision of Care for Overactive Bladder Syndrome- A Real World Evaluation- German Perspective (The Reduce Study)

    Nov 1, 2013, 00:00

  • Physicians’ Preferences for Bone Metastases Treatments in the United States

    Nov 1, 2013, 00:00

  • A Bayesian Multiple Treatment Comparison of Duloxetine, Pregabalin, Gabapentin, Amitriptyline, and Their Combinations for Painful Peripheral Neuropathy Based on Pain Reduction Reported in Clinical Trails

    Nov 1, 2013, 00:00

  • Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012

    Nov 1, 2013, 00:00

  • Patient Networks as a Data Source for Patient Reported Outcomes Research. Carenity Experience

    Nov 1, 2013, 00:00

  • The Impact of the Blind Bid Procedure in Hungary

    Nov 1, 2013, 00:00

  • Potential Financial Impact of Sugammadex in Anaesthetic Departments- A Budget Impact Analysis on Potentially Short Procedures Requiring Neuromuscolar Blockade

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

    Nov 1, 2013, 00:00

  • Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento Cardiovascular

    Nov 1, 2013, 00:00

  • Health Technology Assessment of Contrast-Enhanced Ultrasound (CEUS) Techniques

    Nov 1, 2013, 00:00

  • The Relationship Between COPD Assessment Test (CAT) and EQ-5D in a Real World Patient Population

    Nov 1, 2013, 00:00

  • Epidemiology for Oncological Drugs Regarding the Benefit Dossier Preparation in Germany

    Nov 1, 2013, 00:00

  • Costo-Utilidad De Colágena-Polivinilpirrolidona En El Tratamiento De Osteartrosis De Rodilla I-Ii Frente Al Cuidado Estandar Establecido En Los Protocolos Vigentes De Las Instituciones Publicas En México

    Nov 1, 2013, 00:00

  • How Does the Uncertainty Around the Expected ICER Affect Nice Decisions?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Somatropin Administration with Increased Adherence Due to Monitoring Compared to Non-Monitored Administration in Patients with Growth Hormone Deficiency

    Nov 1, 2013, 00:00

  • Self-Monitoring of Blood Glucose with Insulin Analogues- Nice to Have or Need to Have? Analysis of Phase III Registration Trials and European Public Assessment Reports of Insulin Analogues

    Nov 1, 2013, 00:00

  • Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United States

    Nov 1, 2013, 00:00

  • Clinical and Cost-effectiveness of a Procalcitonin Test as a Prompt Indicator of Prodomol Meningococcal Disease in Febrile Children- Cost-effectiveness Analysis

    Nov 1, 2013, 00:00

  • The Expanding Scope of Comparative Effectiveness Reviews Requires Collaborative Information Systems Solutions

    Nov 1, 2013, 00:00

  • Troika in Portugal- Pharmaceutical Sector from Paper to Reality

    Nov 1, 2013, 00:00

  • Burden of Infusion-Related Costs and Staff Time for Rheumatoid Arthritis in the Hospital Setting

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in Brazil

    Nov 1, 2013, 00:00

  • Análise Das Potencialidades De Custo-Minimização Através Da Determinação Do Market Share Entre Os Quimioterápicos De Referência Que Possuem Genéricos Cadastrados Em Uma Operadora De Plano De Saúde

    Nov 1, 2013, 00:00

  • Prevention of Gram-Positive Infections in Peritoneal Dialysis Patients – A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Patients at the Center of Regulatory Decisions- Using Stated-Preference Data to Help Regulators Answer Difficult Questions

    Nov 1, 2013, 00:00

  • Preference Structure of Clinicians in the Use of Electronic Medical Records; Quantifying the Relative Importance of Barriers and Facilitators of an Innovation

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Periodic Safety Update Reports (PSURS) for Biologicals in Europe

    Nov 1, 2013, 00:00

  • Benefits of Vildagliptin Plus Metformin Combination Therapy in Type 2 Diabetes Mellitus (T2DM) from Patient’s Perspective- Quality of Life (QoL) and Hypoglycemia Burden Analysis

    Nov 1, 2013, 00:00

  • The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

    Nov 1, 2013, 00:00

  • UTILITIES FOR TYPE 2 DIABETES MELLITUS AND ASSOCIATED COMPLICATIONS

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Validity Evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Diferencias En La Consecución De Información Sobre Costos Del Manejo De La Diabetes Mellitus En Colombia

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 Mcg for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

    Nov 1, 2013, 00:00

  • The Impact of Daytime and Nocturnal Non-Severe Hypoglycaemic Events on People with Diabetes in Brazil

    Nov 1, 2013, 00:00

  • Evaluation of the Potential Efficacy of Ivabradine in Health Care of the Republic of Belarus

    Nov 1, 2013, 00:00

  • Resource Use of Non-Small Cell Lung Cancer in Slovakia

    Nov 1, 2013, 00:00

  • Trends in Hospital Admissions Among Men and Women Above the Age of 60 Living in Stockholm and Uppsala Counties in Sweden

    Nov 1, 2013, 00:00

  • An Approach for Quantification of Patient Advocacy Group Input in the HTA Process

    Nov 1, 2013, 00:00

  • Addressing Childhood-Obesity in Mexico- Savings on Health Care Expenditures from Regulating Food and Beverage Sales in Basic Education Schools

    Nov 1, 2013, 00:00

  • Multivariate Network Meta-Analysis of Progression Free Survival and Overall Survival

    Nov 1, 2013, 00:00

  • Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS)- Operational Setup for a Multi-Country, Multi-Center Study

    Nov 1, 2013, 00:00

  • The New Italian Health Care Reform- Introducing New Measures to Speed Up Market Access

    Nov 1, 2013, 00:00

  • Analysis and Classification of Risk-Sharing Schemes Proposed in Reimbursement Application Received by AHTAPol in 2012

    Nov 1, 2013, 00:00

  • Economic Evaluation of Mandibular Advancement Device to Treat Obstructive Sleep Apnea

    Nov 1, 2013, 00:00

  • Who Knows Better? A Knowledge, Attitude and Practice Survey of Osteoporosis Prescreening Tools Among Pharmacists and Physicians

    Nov 1, 2013, 00:00

  • The Burden of Caregiving in Cancer- The Status of Clinical Research

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Agomelatine in Depressed Thai Patients Including the Elderly Depressed Population

    Nov 1, 2013, 00:00

  • Managed Entry Agreements and Orphan Drugs- A European Comparative Study (2006-2012)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal Perspective

    Nov 1, 2013, 00:00

  • Treatment Patterns of Indolent Non-Hodgkin Lymphoma Patients Under the Brazilian Public Health Care Perspective

    Nov 1, 2013, 00:00

  • Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA)

    Nov 1, 2013, 00:00

  • Toxocariasis- A Disease of High Prevalence But Forgotten

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cobas® EGFR Mutation Test Versus Sanger Sequencing in the Treatment of Locally Advanced or Metastatic NSCLC- A Payer Perspective in the United Kingdom

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness and Cost-Utility of Paliperidone Palmitate in the Treatment of Schizophrenia in Guatemala

    Nov 1, 2013, 00:00

  • A Cost-Consequence Analysis of Different Protease Inhibitors Schemes for HIV Treatment from the Colombian Health Care System Perspective

    Nov 1, 2013, 00:00

  • A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar Brasileiro

    Nov 1, 2013, 00:00

  • Profile of Back Pain Sufferers Across 5EU Countries

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Ostomy in Poland- Multicentre Cross-Sectional Study Using WHOQOL-BREF Questionnaire

    Nov 1, 2013, 00:00

  • Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating Tuberculosis

    Nov 1, 2013, 00:00

  • A Lei De Acesso À Informação Fortalece O Papel Da Avaliação De Tecnologias Em Saúde (ATS) De Fornecer Informações Sólidas E Transparentes Aos Usuários Do Sistema Único De Saúde

    Nov 1, 2013, 00:00

  • Reducing the Length of Antibiotic Prophylaxis in Clinical Conditions

    Nov 1, 2013, 00:00

  • The Ecology of Medical Care in Poor Settings- Self Reported Health Care Utilization in Santiago Del Estero, Argentina

    Nov 1, 2013, 00:00

  • Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, Brazil

    Nov 1, 2013, 00:00

  • Changes in Patient-Reported Outcomes Among Pediatric Leukemia and Lymphoma Patients During the First 2-Years Post Allogeneic Stem Cell Transplantation (alloSCT)

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Infant Pneumococcal Vaccination in the Netherlands

    Nov 1, 2013, 00:00

  • Resources Saved by the Introduction of Day Surgery in the Greek National Health System

    Nov 1, 2013, 00:00

  • An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

    Nov 1, 2013, 00:00

  • Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries

    Nov 1, 2013, 00:00

  • Patient Eligibility and Use of Biologics in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis in the United States

    Nov 1, 2013, 00:00

  • Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States

    Nov 1, 2013, 00:00

  • Short-Term Disability (STD) Associated with Skeletal Related Events (SRES) in Commercially Insured Patients with Bone Metastases (BM) Secondary to Solid Tumors

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Analysing the Access to Priority Health Services in the Adolescent Population in Six Provinces in Northern Argentina

    Nov 1, 2013, 00:00

  • Basic Attitude Towards Health Care Resource Allocation Decision Making in Japanese People -Utilitarianism or Egalitarianism?

    Nov 1, 2013, 00:00

  • Assessing the Fiscal Consequences of Immunizing the Female and Male Population Against Human Papillomavirus (HPV) in Germany

    Nov 1, 2013, 00:00

  • Developing a Population-Based Dementia Registry Focusing on Patients and Carer Needs- Methodological Challenges

    Nov 1, 2013, 00:00

  • Costs Comparison of Cutaneous Drug Reactions Treatment Divided by Diagnosis Groups

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Comparison of Genotype 1 Hepatitis C Virus (HCV) Treatments Using Telaprevir (TVR) in Patients with Mild Fibrosis Versus Patients with Bridging Fibrosis and Cirrhosis

    Nov 1, 2013, 00:00

  • Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D

    Nov 1, 2013, 00:00

  • Investigating the Impact of Mental Health Status on Health and Social Care Costs of Older People after Acute Hospital Admission

    Nov 1, 2013, 00:00

  • Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care Context

    Nov 1, 2013, 00:00

  • Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients- A French National Claims Database Analysis Over the Period 2009-2011

    Nov 1, 2013, 00:00

  • Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings- An Individual Patient Data Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Hepatitis a Vaccine Policy Process in 6 Countries – Factors Influencing Potential Adoption

    Nov 1, 2013, 00:00

  • Poder Popular Y Regulación Del Precio De Los Medicamentos En Venezuela

    Nov 1, 2013, 00:00

  • Economic Analysis of Protease Inhibitors in First-Line Haart in Adult Patients with HIV

    Nov 1, 2013, 00:00

  • Characteristics of Children and Adolescents Using Proton Pump Inhibitors or Histamine-2-Receptor Antagonists- Analysis of Thin and Pharmo Databases

    Nov 1, 2013, 00:00

  • Improvements in Physical Function, Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis Treated with Golimumab- Sub-Analysis of Latin American Patients Enrolled in Mulitcentre Phase III Clinical Trials

    Nov 1, 2013, 00:00

  • Orphan Drugs in the German Early Benefit Assessment– Real World Versus G-Ba Bureaucracy

    Nov 1, 2013, 00:00

  • Health Economic Analyses in Medical Nutrition- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Clinical Effectiveness of Lacosamide and Its Impact on Concomitant Antiepileptic Drugs Consumption in the Czech Republic

    Nov 1, 2013, 00:00

  • Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Issues with Cost-Effectiveness Modelling of Diagnostic Tests – Case Study of Ischaemic Cardiomyopathy

    Nov 1, 2013, 00:00

  • Desarrollo De Una Escala De Estructuras Y Proceso Para La Evaluación De Los Centros De Hemodiálisis

    Nov 1, 2013, 00:00

  • Haemophilia A- Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in Fran We Should Compare the Cost Per Patient Instead of the Price Per Unit

    Nov 1, 2013, 00:00

  • Costos Económicos Asociados A Secuelas De Meningitis En Colombia

    Nov 1, 2013, 00:00

  • Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis- Results from the Open-Label Extension Study of Rapi ...

    Nov 1, 2013, 00:00

  • Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs Program

    Nov 1, 2013, 00:00

  • Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis Treatments

    Nov 1, 2013, 00:00

  • Comprehensive Overview- Efficacy, Tolerability and Cost- Effectiveness of Irbesartan

    Nov 1, 2013, 00:00

  • Reasons Given by the European Medicines Agency for Revising Disease-Specific Scientific Guidelines

    Nov 1, 2013, 00:00

  • Study and Evaluation of Medication Errors in Diabetic Patients in Medicine Ward of a Secondary Care Community Hospital at Mumbai, India

    Nov 1, 2013, 00:00

  • Predictor Factors for the Presence of Post Herpetic Neuralgia at 3 Months in Herpes Zoster Patients Aged 50 and Over in Italy- Results from a Gp-Based Observational Prospective Multicenter Study

    Nov 1, 2013, 00:00

  • Systematic Review- The Economic Burden of Crohn’s Disease in Europe in Adults and Children

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Renal Post-Transplant Prophylaxis with Belatacept in Colombia

    Nov 1, 2013, 00:00

  • Using Feedback from Patients in Determining Suitability of the Perceived Deficits Questionnaire (PDQ) and the Resource Utilization in Dementia-Lite (RUD-Lite) for Use in Clinical Trials in Prodromal Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naïve Patients Considered Biologic-Suitable in the United States

    Nov 1, 2013, 00:00

  • Resource Use and Disease Progression Among HCV-Positive Patients

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients Diagnosed with Obesity in the United States

    Nov 1, 2013, 00:00

  • Patients with Hypertension in Primary Care in Spain- Management, Self-Perception and Satisfaction

    Nov 1, 2013, 00:00

  • Are the Biotechnology and Pharmaceutical Sectors Defensive Relative to the SP 500?

    Nov 1, 2013, 00:00

  • The Influence of HAQ Utility Mapping Algorithms on the Cost-Effectiveness of Second Line Biologics for Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Measurements of Adherence to Oral Therapies Among Brazilian Patients- A Systematic Review

    Nov 1, 2013, 00:00

  • Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

    Nov 1, 2013, 00:00

  • Predicting Health Care Costs in Asthma Using the EQ-5D Index Score

    Nov 1, 2013, 00:00

  • Dabigatran Etexilate in Prevention of Stroke for Nonvalvular Atrial Fibrillation Patients in Turkish Health Care Setting; A Study on Cost Containment of Social Security Institution (SSI)

    Nov 1, 2013, 00:00

  • The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an Analgesic

    Nov 1, 2013, 00:00

  • Comparing Costs and Consequences of Treating Chronic Obstructive Pulmonary Disease with Budesonide/Formoterol and Fluticasone/Salmeterol

    Nov 1, 2013, 00:00

  • Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC)- Mean Overall Survival (OS) in a “Better Responders” Patient Population of the Velour Trial

    Nov 1, 2013, 00:00

  • Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe- Acesso E Impacto Econômico Em Um Hospital Universitário

    Nov 1, 2013, 00:00

  • Use of Beta Blocking Agents in Serbia in the Period from 2007 to 2011 Year

    Nov 1, 2013, 00:00

  • Health and Social Care Resource Use by Individuals with Fragile X Syndrome- Results of Two Delphi Panels

    Nov 1, 2013, 00:00

  • Re-Engineering of the Distribution of Drugs in the Hospital. TOC Application and TRZ

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in Russia

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Subcutaneous Abatacept in the Treatment of Rheumatoid Arthritis in Spain

    Nov 1, 2013, 00:00

  • Atrial Fibrillation’s Burden of Disease in Portugal

    Nov 1, 2013, 00:00

  • Efficacy and Tolerability of CT-Guided Epidural Steroid Injections and Pharmacotherapy for Managing Chronic Low Back Ache with Radiculopathy

    Nov 1, 2013, 00:00

  • Canadian Burden of Choroidal Neovascularization Secondary to Pathologic Myopia- Baseline Characteristics of Patients

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care System

    Nov 1, 2013, 00:00

  • Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate

    Nov 1, 2013, 00:00

  • Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012

    Nov 1, 2013, 00:00

  • Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis- What to Do When a Biologic Fails

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Multiple Outcomes- A Simulation Study and Application

    Nov 1, 2013, 00:00

  • Cost Per Cure of Telaprevir and Boceprevir in Treatment-Naïve Genotype 1 Hepatitis C Patients with F2 Fibrosis in Brazil

    Nov 1, 2013, 00:00

  • A Proposed 6-Item Reduction for the European Organization for the Research and Treatment of Cancer-Quality of Core Questionnaire (EORTC QLQ-C30) - Cuban Group of Trialists on Epidermal Growth Factor (CGT-EGF)

    Nov 1, 2013, 00:00

  • Natalizumab for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients- 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective

    Nov 1, 2013, 00:00

  • Persistence Patterns with Oral Hypoglycaemic Medicines (OHM) in Newly Treated Irish Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Budget Impact of Switching from an Immediate-Release to a Prolonged-Release Formulation of Tacrolimus in Renal Transplant Recipients in the UK Based on Differences in Adherence

    Nov 1, 2013, 00:00

  • How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?

    Nov 1, 2013, 00:00

  • Markov Models in Non Metastatic Prostate Cancer – Availability of Input Factors and Structurural Uncertainty

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction

    Nov 1, 2013, 00:00

  • Systematic Review Comparing the Efficacy and Safety of Collagenase Clostridium Histolyticum (Xiaflex®) Injection with Surgical Fasciectomy for the Treatment of Dupuytren’s Contracture

    Nov 1, 2013, 00:00

  • Psychometric Properties of the Hypoglycemia Perspectives Questionnaire (HPQ) in Type 2 Diabetes Mellitus

    Nov 1, 2013, 00:00

  • Eliciting the Relative Importance of Key Elements for Benefit-Risk Assessment- A Comparison Among General Population, Health Authority and Medical Doctors

    Nov 1, 2013, 00:00

  • Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial

    Nov 1, 2013, 00:00

  • Medication Treatment and Health Care Utilization for Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany

    Nov 1, 2013, 00:00

  • Potential Predictors of Alzheimer’s Disease- An Analysis with the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Increased Risk of Cancer Incidence Associated with Repeat Medical Imaging- Designing Better Clinical Trial Protocols

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Antimicrobials as Treatment for Patients with Complicated Skin and Soft Tissues Infections- A Comparison Between Ceftaroline, Linezolid and Vancomycin in the Russian Health Care

    Nov 1, 2013, 00:00

  • Estudio Transversal Del Proceso De Actualización De Medicamentos En El Cuadro Básico Y Catálogo De Insumos Del Sector Salud

    Nov 1, 2013, 00:00

  • Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget

    Nov 1, 2013, 00:00

  • Cost of Obesity and Economic Value of Obesity Surgery for Turkey (CEVOS-T)

    Nov 1, 2013, 00:00

  • The Importance of Sensitivity Analyses in Health Technology Assessments

    Nov 1, 2013, 00:00

  • IQWIG’s Efficiency Frontier Approach- Fit for Purpose!

    Nov 1, 2013, 00:00

  • Two Simple Methods of Measuring Adherence in Hypertensive Patients Are Predictive of Blood Pressure Control- Pooled Analysis of 17,516 Patients from Seven Valsartan Studies

    Nov 1, 2013, 00:00

  • Análisis Economico De La Profilaxis Secundaria Versus El Tratamiento a Demanda De Una Cohorte De Pacientes Colombianos Con Hemofilia a Y B Severa

    Nov 1, 2013, 00:00

  • Dealing with Zero Cells in Sparse Networks in Bayesian Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Quality of Life (QOL) and Resources Consumption in Insulin-Dependent Diabetic Patients with A1CNOW+ and CONTOUR USB. Comet Study

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess the Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU)

    Nov 1, 2013, 00:00

  • Naturalistic Disease Management Study of Patients with Alcohol Dependence in the Primary Care Setting in the United Kingdom (STREAM)

    Nov 1, 2013, 00:00

  • A Study of A. Baumannii in a Tertiary Care Hospital with Consideration to Risk Factors of Infection and Resistance Pattern

    Nov 1, 2013, 00:00

  • Building a Real World Practice-Based Network Data Platform to Link Rare Disease Patients- Case Study of Myelofibrosis Patients in the United States

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life (HRQL) in Chronic Hepatitis C (CH-C) Patients Treated with Sofosbuvir Containing Interferon-Free Regimens

    Nov 1, 2013, 00:00

  • Unmet Health Needs of Immigrants Living in Greece During the Economic Crisis- The Long-Term Impact for the Health Care System

    Nov 1, 2013, 00:00

  • Continued Improvements in Workplace and Household Productivity with Certolizumab Pegol Treatment in Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 48-Week Results from the Rapid-axSpA ...

    Nov 1, 2013, 00:00

  • Direct Medical Costs of Treating Diabetes-Related Complications in Argentina

    Nov 1, 2013, 00:00

  • Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil- Results from a 12-Month Retrospective Analysis of an Administrative Database

    Nov 1, 2013, 00:00

  • 2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDS

    Nov 1, 2013, 00:00

  • Mood Stabilizers and Atypical Antipsychotics in Maintenance Therapy for Bipolar Disorder- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Medición De La Calidad De Vida Por Medio Del “Dermatology Life Quality Index” En Pacientes Con Psoriasis- Una Revisión Sistemática

    Nov 1, 2013, 00:00

  • Use of the French Claims and Hospitalisations Database to Estimate the Prevalence and Incidence of Parkinson’s Disease in France

    Nov 1, 2013, 00:00

  • Analysis of Published Health Technology Assessments (HTA) in Russia and Its Place in Russian Reimbursement System

    Nov 1, 2013, 00:00

  • The Costs of Managing Genital Warts in the UK by Devolved Nation- England, Scotland, Wales and Northern Ireland

    Nov 1, 2013, 00:00

  • Frecuencia Y Costos De Hospitalización En Una Población De Pacientes En Dialisis En Colombia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

    Nov 1, 2013, 00:00

  • Future Costs Inclusion in Published Economic Evaluations- What Is the Current Situation?

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Accepting Submissions with ICERs Higher Than the Threshold

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life (HRQoL) in Patients Treated by Novel Oral Anticoagulants (NOACs)- Reduced Version of the Sawicki Questionnaire

    Nov 1, 2013, 00:00

  • Cost of Cancer in the Austrian Hospital Setting

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary Care

    Nov 1, 2013, 00:00

  • Consumption Patterns, Market Characteristics and Regulation in the Pharmaceutical Industry- Evidence from Two Therapeutic Groups in Insured Population in Argentina

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Diferent Anti-Parkinsonian Drugs Used in Monopherapy During Early Stages of Parkinson Disease

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Anti-Rabies Prophylaxis After Exposure to Unobservable Dogs in Eradication Context- The French Case

    Nov 1, 2013, 00:00

  • The Impact of Chlamydia and Gonorrhoea Point of Care Nucleic Acid Amplification Tests on Clinical Pathways and Costs in Genito-Urinary Medicine Clinics in the United Kingdom

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico

    Nov 1, 2013, 00:00

  • Evaluation of Home Medication Review in Community Out Reach Program

    Nov 1, 2013, 00:00

  • Cost Analysis of Proton Pump Inhibitors in the Treatment of Ulcer Duodenum in Ukraine

    Nov 1, 2013, 00:00

  • The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)

    Nov 1, 2013, 00:00

  • Health Care Costs Associated with Chronic Hepatitis C Infection in Europe

    Nov 1, 2013, 00:00

  • Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the Netherlands

    Nov 1, 2013, 00:00

  • Projeção De Gastos Com Medicamentos De Uso Crônico (Ambulatorial)

    Nov 1, 2013, 00:00

  • The Role of Half-Cycle Correction in the Models Used for Health Technology Assessment

    Nov 1, 2013, 00:00

  • Systematic Review of Patient Reported Outcomes in Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Exploratory Structural Equation Models- A Simulation Study Exploring Geomin and Target Rotation Techniques on Variations of ESEM Models

    Nov 1, 2013, 00:00

  • Assessing Quality of Life in Adult Growth Hormone Deficiency- Further Development of the QoL-AGHDA

    Nov 1, 2013, 00:00

  • The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life

    Nov 1, 2013, 00:00

  • Calibration of a Cost-Effectiveness Model to Evaluate the Incorporation of a Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Argentina- Disease Burden Component

    Nov 1, 2013, 00:00

  • The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality- An Ecological Study

    Nov 1, 2013, 00:00

  • Breast Cancer Screening Program in the Basque Country- Costs and Health Benefits Assessment Through Discrete Event Simulation

    Nov 1, 2013, 00:00

  • Adherence to Disease-Specific Recommendations for Pharmacoeconomic Studies in Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Importance of Subgroup Analyses for Health Technology Assessments

    Nov 1, 2013, 00:00

  • Health Care Resource Use and Direct Costs Associated with Fragile X Syndrome (FXS) in the United States

    Nov 1, 2013, 00:00

  • Use of Surrogate Outcomes in Health Technology Assessments (HTAs)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Basiliximab As Induction Therapy for Kidney Transplantation in Mexico

    Nov 1, 2013, 00:00

  • Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Five European Countries

    Nov 1, 2013, 00:00

  • Development of the Scharr HUD (Health Utilities Database)

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Multifocal and Monofocal Intraocular Lenses in Cataract Surgery in the Czech Republic

    Nov 1, 2013, 00:00

  • Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De Trasplantes

    Nov 1, 2013, 00:00

  • Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors- The Equade Study

    Nov 1, 2013, 00:00

  • Reliability and Validity of a Thai Version of Lam Employment Absence and Productivity Scale (LEAPS)

    Nov 1, 2013, 00:00

  • Active-Implantable Cardiac Devices- Is There Room for Cost Savings in Portuguese Hospitals?

    Nov 1, 2013, 00:00

  • Budget Impact of Everolimus for Tuberous Sclerosis Complex (TSC) Related Angiomyolipoma (AML)- United Kingdom Perspective

    Nov 1, 2013, 00:00

  • Costs of Acute Heart Failure in France

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Incorporation of the HPV Vaccine to the National Immunization Program / NIP of Brazil

    Nov 1, 2013, 00:00

  • A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan

    Nov 1, 2013, 00:00

  • Early-Stage Economic Evaluation of Stratified Medicine in Multiple Myeloma

    Nov 1, 2013, 00:00

  • Analysis of Health Care Costs in Elderly Patients with Multiple Chronic Conditions Using a Finite Mixture of Generalized Linear Models

    Nov 1, 2013, 00:00

  • Predictors of Costs of Antiretrovirals for HIV Infection in Italy- A Multicentric Retrospection in 2012

    Nov 1, 2013, 00:00

  • Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico- A Comparison to Sweden

    Nov 1, 2013, 00:00

  • A Systematic Review on the Effect of Behavioral Versus Surgical Intervention on Obese Patients’ Psychological Well-Being

    Nov 1, 2013, 00:00

  • Bayesian Evidence Synthesis of Safety Data- A Robust Option?

    Nov 1, 2013, 00:00

  • Does HTA Process Help to Achieve the Health Objectives of the Millennium? A South American Analysis

    Nov 1, 2013, 00:00

  • Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review

    Nov 1, 2013, 00:00

  • Diabetic Patients in Primary Care- Self-Perception and Satisfaction. Comparative Study Spain Versus Europe

    Nov 1, 2013, 00:00

  • Health Care Utilization and Expenditures of Osteoporosis Patients Treated with Oral Bisphosphonate in Tianjin, China

    Nov 1, 2013, 00:00

  • Comparative Efficacy and Metabolic Side Effects of Lurasidone for the Management of Acute Schizophrenia- A Systematic Literature Review and Mixed Treatment Comparison with First and Second Generation Antipsychotics

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Anti-Inhibitor Coagulant Complex (AICC) in the Treatment of Inhibitor Hemophilia

    Nov 1, 2013, 00:00

  • Differential Item Functioning in a Satisfaction Item Bank

    Nov 1, 2013, 00:00

  • Evaluation of Acute Pancreatitis Signals with Incretin Enhancers- Revisiting Disproportionality Analysis of the Adverse Event Reporting System

    Nov 1, 2013, 00:00

  • The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation- A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Intralesional Injection of Recombinant Human Epidermal Growth Factor for the Treatment of Severe Diabetic Foot Ulcers in Russian Health Care Setting

    Nov 1, 2013, 00:00

  • Estimating and Modeling Long Term Survival in Lung Cancer Using Mixture Parametric Models

    Nov 1, 2013, 00:00

  • Correlations Between Changes in the Urticaria Activity Score (UAS7) and the Dermatology Life Quality Index (DLQI) from Baseline to 28 or 40 Weeks- Comparisons of Trajectories of Change in Patients with Chronic Spontaneous/Idiopathic Urticar ...

    Nov 1, 2013, 00:00

  • How Can Health Economic Assessment Methods Help Decision Making in Portfolio Development

    Nov 1, 2013, 00:00

  • An Economic Evaluation Comparing ePTFE Covered Stent-Grafts Configured for Tips with Bare Metal Stents in Procedures for the Treatment of Portal Hypertension Complications

    Nov 1, 2013, 00:00

  • Study of Antibiotic Consumption Pattern in Hospital Acquired Pneumonia

    Nov 1, 2013, 00:00

  • Usefulness of a Commercial Hospital Claims Database to Identify Current Anti-Vascular Endothelial Growth Factor Treatment Patterns in Patients with Exudative Age-Related Macular Degeneration in Japan

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ranibuzumab for the Treatment of Myopic Choroidal Neovascularization in Canada

    Nov 1, 2013, 00:00

  • Cost Burden of Rotavirus Gastro-enteritis Requiring Hospitalizations in the Czech Republic and in Slovakia

    Nov 1, 2013, 00:00

  • Meta-Analysis of Efficacy of Etanercept for Treatment of Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Examining the Relationship Between Country-Level Factors and Vaccine Wastage- A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

    Nov 1, 2013, 00:00

  • Contribution of Latin America to Mental Health in Pregnancy

    Nov 1, 2013, 00:00

  • Responsiveness of the EQ-5D in Oncology- A Meta-Analysis

    Nov 1, 2013, 00:00

  • Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in German Patients with Schizophrenia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Compared to Basiliximab in the Induction of Renal Transplant Patients

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization Costs Related to Anaemia Management in Chronic Kidney Disease Non-Dialysed Patients- A Retrospective Clinical and Administrative Database Analysis

    Nov 1, 2013, 00:00

  • Are Head-To-Head Data Necessary to Gain Reimbursement in the French National Health Care System?

    Nov 1, 2013, 00:00

  • O Uso De Temozolomida No Tratamento De Astrocitoma De Baixo Grau – Câncer No Cérebro

    Nov 1, 2013, 00:00

  • Draft Versus Final Guidance in Nice’s Drug Technology Appraisal Process

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Apixaban Versus Rivaroxaban for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Estrategias De Prevención Primaria Y Secundaria Para Cáncer De Cuello Uterino En Colombia

    Nov 1, 2013, 00:00

  • Are Conditionally Approved Therapies Successful in Gaining Market Access?

    Nov 1, 2013, 00:00

  • Cost Utility Analysis of Screening and Treatment of Hyperlipidemia in Chinese Adults Aged 45 and Above

    Nov 1, 2013, 00:00

  • Using the Delphi Method for Selecting Medical Technologies Under Budget Constraints- A Feasibility Study

    Nov 1, 2013, 00:00

  • Determinants of Prompt Access to Health Care in CHPS Programme in Rural Communities of Bawjiase, Ghana

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa Therapy

    Nov 1, 2013, 00:00

  • Prevalence and Risk Factors of Actinic Keratoses

    Nov 1, 2013, 00:00

  • Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales

    Nov 1, 2013, 00:00

  • The Relationship Between Specific Annual Bleed Rates and Health Outcomes Among Children with Severe Hemophilia a in Latin America

    Nov 1, 2013, 00:00

  • Recent Trends in Incidence and Demographics of Pediatric Meningococcal Disease in the United States

    Nov 1, 2013, 00:00

  • Implementation of International Chart Review Studies- An Assessment of Key Design and Operational Considerations for Successful Conduct

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Pulmonary Veins Isolation with Cryo Technique

    Nov 1, 2013, 00:00

  • Which Cystic Fibrosis Inhaled Antibiotic Medicine Features Matter Most to Adult Patients and Parents of Pediatric Patients?

    Nov 1, 2013, 00:00

  • Assesment of the Cost of Biological Therapy in Rheumatic Diseases- Economic Impact of Dosage Modification in Clinical Practice

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Ranibizumab in Age-Related Macular Degeneration Based on Real-Life Observational Data in France

    Nov 1, 2013, 00:00

  • Inference on Incremental Cost Effectiveness Thresholds Influencing Nice Decisions- A Bayesian Analysis

    Nov 1, 2013, 00:00

  • Real World Resource Use Associated with Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement Surgery

    Nov 1, 2013, 00:00

  • Clinical Outcomes of Patients with Major Depressive Disorder Treated with Either Duloxetine or Selective Serotonin Reuptake Inhibitors in Mexico

    Nov 1, 2013, 00:00

  • Patterns in Asthma Medicationtreatment in the United States

    Nov 1, 2013, 00:00

  • Cost of Influenza in Germany

    Nov 1, 2013, 00:00

  • Defining the Proper Methodology to Use in a Data-Peek for Power (DPP)

    Nov 1, 2013, 00:00

  • Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors

    Nov 1, 2013, 00:00

  • GLP1 and Insulin Glargine Treatment Patterns Among Type 2 Diabetes Patients in Major EU Markets

    Nov 1, 2013, 00:00

  • Copyright/Subscription

    Nov 1, 2013, 00:00

  • Relationship Between Falls and CNS Drugs at a Acute Care Teaching Hospital in Japan

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan

    Nov 1, 2013, 00:00

  • Disease Burden of Ischemic Stroke Along First Year Post-Stroke in Spain

    Nov 1, 2013, 00:00

  • Biological Agents in the Treatment of Moderate to Severe Psoriasis- A Pharmacoeconomic Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom

    Nov 1, 2013, 00:00

  • Impact of the German Amnog Evaluation on Drug Prices- Correlation of Rebate?

    Nov 1, 2013, 00:00

  • Treatment Patterns and Burden of Illness of Cushing’s Disease in the United Kingdom- Real World (RW) Data from Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Long-Term Maintenance of Improvements in Patient-Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 48-Week Results of the Rapid ...

    Nov 1, 2013, 00:00

  • Single Use Devices in Argentina- Economic Evaluation of a “Reuse” Versus a “Single Use” Policy

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life of Hemodialysis Patients in Indonesia

    Nov 1, 2013, 00:00

  • Burden of Actinic Keratosis in Germany-Results of a Literature Research

    Nov 1, 2013, 00:00

  • The Direct Costs of Drug-Induced Skin Reactions in Poland

    Nov 1, 2013, 00:00

  • Paper-Based and Electronic Assessment of Health-Related Quality of Life Specific to HIV Disease- A Reliability Study with the PROQOL-HIV Questionnaire

    Nov 1, 2013, 00:00

  • Treatment Patterns and Health Care Resource Utilization of Patients with Acromegaly in the United States

    Nov 1, 2013, 00:00

  • Impact of Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens in the Management of Advanced Esophago-Gastric Cancer in Hong Kong

    Nov 1, 2013, 00:00

  • The Budget Impact of Qutenza® for the Treatment of Neuropathic Pain in Sweden

    Nov 1, 2013, 00:00

  • Economic Implications of Alternative Treatments and Care Locations for Acute Bacterial Skin and Skin Structure Infections with Suspected MRSA

    Nov 1, 2013, 00:00

  • Diminishing Marginal Disutility of Hypoglycaemic Events

    Nov 1, 2013, 00:00

  • Cost and Cost-Effectiveness of Treating Urgency Stress Incontinence-Results from a Randomized Controlled Trial

    Nov 1, 2013, 00:00

  • Developing a Publication Strategy in the Context of Outcome Research- A Review of the Literature

    Nov 1, 2013, 00:00

  • Economical Justification of the Innovation Method of Laboratory Diagnostic of the Structural and Functional Changes of Serum Albumin in Septic Complications (Ata-Test)

    Nov 1, 2013, 00:00

  • Cost-Utility of Apixaban Compared to Warfarin for Stroke Prevention in Patients with Atrial Fibrillation in Colombia

    Nov 1, 2013, 00:00

  • Pricing and Reimbursement Analysis of Lifestyle Medicines in Serbia

    Nov 1, 2013, 00:00

  • Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy Candidates

    Nov 1, 2013, 00:00

  • Fixed Reference Pricing or Benefit Assessment of Established Products – from the Frying Pan into the Fire?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Private Health Care System

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Ferumoxytol in the Management of Anemia in Patients with Chronic Kidney Disease in Belgium

    Nov 1, 2013, 00:00

  • Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia

    Nov 1, 2013, 00:00

  • What Value Can Operational Feasibility Studies Bring to Post Marketing Observational Studies (PMOS)? Example of Feasibility Study Performed in Eastern Europe to Assess Hepatitis C Viral Disease/Patient Management in Real World Setting

    Nov 1, 2013, 00:00

  • Results of Galata Study- Galvus Efficacy and Safety Assessment in Turkish Population

    Nov 1, 2013, 00:00

  • Value of Life- As Perceived by Physicians and the General Public

    Nov 1, 2013, 00:00

  • Psoriasis Patients’ Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

    Nov 1, 2013, 00:00

  • The Current Management and Costs of Irritable Bowel Syndrome with Constipation in Belgium- A 2-Round Expert Survey

    Nov 1, 2013, 00:00

  • Change of Burden of Disease in German Rheumatoid Arthritis Patients Since the Uptake of TNF-Inhibitors- A Literature Review of German Real Life Data

    Nov 1, 2013, 00:00

  • Impact of Treatment Failure on the Total Cost of Triple Therapy Including Boceprevir or Telaprevir Based on the French Early Access Program (ANRS CO20-CUPIC) Study

    Nov 1, 2013, 00:00

  • Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment- Results of a Survey Among French Patients

    Nov 1, 2013, 00:00

  • A Comparison of the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Diabetes in the United States

    Nov 1, 2013, 00:00

  • Analysis of Public and Private Hospital Databases (PMSI) 2010 / 2011 to Estimate the Frequency and Associated Costs for Febrile Neutropenia in France

    Nov 1, 2013, 00:00

  • Tecepoc Study. How to Improve the Inhalation Techniques in Patient with COPD. The Influence of Preferences

    Nov 1, 2013, 00:00

  • Analysis of Brazilian Public Funding Process for New Biologic Drugs

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117 (current)
  • 118
  • 119
  • 120
  • »